Prescription
Targeted cancer therapy (antibody-drug conjugate)
Trastuzumab emtansine
Last reviewed April 2026
Who is this for?
What is this drug?
Trastuzumab emtansine (sold as Kadcyla in Nigeria) is a targeted cancer medicine that combines an antibody with a powerful chemotherapy drug. It attaches specifically to HER2 protein on certain breast cancer cells and delivers the chemotherapy directly into those cells, killing them while sparing most healthy cells.
What is it used for?
HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer)early-stage HER2-positive breast cancer after surgery when there is still some cancer remaining
Prescription Required
A doctor's prescription is required to obtain this drug legally.